RNAi Technology Market Size, Share, and Outlook, H2-2025 Report- By Application (Drug Discovery and Development , Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis, Neurological Disorders, Others)) and Companies, 2021-2032
Description
RNAi Technology Market Outlook
The global RNAi Technology Market Size is valued at $3.5 Billion in 2025 and is forecast to reach $9.5 Billion in 2032 at a CAGR of 15.3%.
The RNAi Technology Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on RNAi Technology Market segments across 22 countries from 2021 to 2032. Key segments covered include By Application (Drug Discovery and Development , Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis, Neurological Disorders, Others)), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
RNAi Technology Market Insights, 2025
RNA interference (RNAi) technology has evolved into a powerful tool not only for therapeutics but also for functional genomics, agriculture, and diagnostics. Recent developments include sophisticated RNAi platforms that enable selective gene silencing with enhanced specificity and minimal off-target effects. Advances in chemical modifications of siRNA molecules improve stability and reduce immune activation. Delivery systems incorporating lipid nanoparticles, polymeric carriers, and conjugates have broadened RNAi’s clinical applicability. RNAi technology is increasingly integrated with CRISPR and other gene editing tools to enable combinatorial gene modulation. The technology’s use in antiviral therapies and cancer immunotherapy is expanding rapidly, supported by ongoing clinical trials. Industrial applications include RNAi-based pest control in agriculture, reducing reliance on chemical pesticides. Diagnostic applications harness RNAi for biomarker validation and target identification. Regulatory landscapes continue to evolve, balancing innovation with safety monitoring. Collaborative efforts between academia and industry accelerate RNAi technology optimization and commercialization.
Five Trends Shaping the Global RNAi Technology Market in 2025 and Beyond
The global RNAi Technology Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the RNAi Technology Industry?
The RNAi Technology Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, RNAi Technology Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
RNAi Technology Market Segment Insights
The RNAi Technology Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Application (Drug Discovery and Development , Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis, Neurological Disorders, Others)). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
RNAi Technology Industry Value Chain
The chapter identifies potential companies and their operations across the global RNAi Technology Industry ecosystem. It assists decision-makers in evaluating global RNAi Technology Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the RNAi Technology Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific RNAi Technology Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for RNAi Technology Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States RNAi Technology Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American RNAi Technology Market.
Europe RNAi Technology Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for RNAi Technology Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for RNAi Technology Industry competitiveness. The report analyses the key RNAi Technology Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American RNAi Technology Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international RNAi Technology Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa RNAi Technology Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for RNAi Technology Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How RNAi Technology Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the RNAi Technology Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Alnylam Pharmaceuticals, Arcturus Therapeutics, Arrowhead Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Merck & Co. Inc, Novo Nordisk A/S, Phio Pharmaceuticals Corp, Qiagen NV, Silence Therapeutics PLC, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
RNAi Technology Market Scope
Leading Segments
By Application
Drug Discovery and Development
TherapeuticsOncology Ocular Disorders Respiratory Disorders Hepatitis B and C Autoimmune Hepatitis Neurological Disorders Others
Leading Companies
Alnylam Pharmaceuticals
Arcturus Therapeutics
Arrowhead Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Merck & Co. Inc
Novo Nordisk A/S
Phio Pharmaceuticals Corp
Qiagen NV
Silence Therapeutics PLC
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global RNAi Technology Market Size is valued at $3.5 Billion in 2025 and is forecast to reach $9.5 Billion in 2032 at a CAGR of 15.3%.
The RNAi Technology Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on RNAi Technology Market segments across 22 countries from 2021 to 2032. Key segments covered include By Application (Drug Discovery and Development , Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis, Neurological Disorders, Others)), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
RNAi Technology Market Insights, 2025
RNA interference (RNAi) technology has evolved into a powerful tool not only for therapeutics but also for functional genomics, agriculture, and diagnostics. Recent developments include sophisticated RNAi platforms that enable selective gene silencing with enhanced specificity and minimal off-target effects. Advances in chemical modifications of siRNA molecules improve stability and reduce immune activation. Delivery systems incorporating lipid nanoparticles, polymeric carriers, and conjugates have broadened RNAi’s clinical applicability. RNAi technology is increasingly integrated with CRISPR and other gene editing tools to enable combinatorial gene modulation. The technology’s use in antiviral therapies and cancer immunotherapy is expanding rapidly, supported by ongoing clinical trials. Industrial applications include RNAi-based pest control in agriculture, reducing reliance on chemical pesticides. Diagnostic applications harness RNAi for biomarker validation and target identification. Regulatory landscapes continue to evolve, balancing innovation with safety monitoring. Collaborative efforts between academia and industry accelerate RNAi technology optimization and commercialization.
Five Trends Shaping the Global RNAi Technology Market in 2025 and Beyond
The global RNAi Technology Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the RNAi Technology Industry?
The RNAi Technology Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, RNAi Technology Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
RNAi Technology Market Segment Insights
The RNAi Technology Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Application (Drug Discovery and Development , Therapeutics (Oncology, Ocular Disorders, Respiratory Disorders, Hepatitis, Neurological Disorders, Others)). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
RNAi Technology Industry Value Chain
The chapter identifies potential companies and their operations across the global RNAi Technology Industry ecosystem. It assists decision-makers in evaluating global RNAi Technology Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the RNAi Technology Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific RNAi Technology Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for RNAi Technology Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States RNAi Technology Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American RNAi Technology Market.
Europe RNAi Technology Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for RNAi Technology Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for RNAi Technology Industry competitiveness. The report analyses the key RNAi Technology Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American RNAi Technology Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international RNAi Technology Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa RNAi Technology Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for RNAi Technology Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How RNAi Technology Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the RNAi Technology Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Alnylam Pharmaceuticals, Arcturus Therapeutics, Arrowhead Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Merck & Co. Inc, Novo Nordisk A/S, Phio Pharmaceuticals Corp, Qiagen NV, Silence Therapeutics PLC, Thermo Fisher Scientific Inc. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
RNAi Technology Market Scope
Leading Segments
By Application
Drug Discovery and Development
Therapeutics
Leading Companies
Alnylam Pharmaceuticals
Arcturus Therapeutics
Arrowhead Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Merck & Co. Inc
Novo Nordisk A/S
Phio Pharmaceuticals Corp
Qiagen NV
Silence Therapeutics PLC
Thermo Fisher Scientific Inc
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
194 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 RNAi Technology Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest RNAi Technology Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global RNAi Technology Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 RNAi Technology Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. RNAi Technology Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Application
- Drug Discovery and Development
- Therapeutics
- -Oncology
- -Ocular Disorders
- -Respiratory Disorders
- -Hepatitis B and C
- -Autoimmune Hepatitis
- -Neurological Disorders
- -Others
- 6. Global RNAi Technology Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America RNAi Technology Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America RNAi Technology Market Trends and Growth Opportunities
- 6.2.1 North America RNAi Technology Market Outlook by Type
- 6.2.2 North America RNAi Technology Market Outlook by Application
- 6.3 North America RNAi Technology Market Outlook by Country
- 6.3.1 The US RNAi Technology Market Outlook, 2021- 2032
- 6.3.2 Canada RNAi Technology Market Outlook, 2021- 2032
- 6.3.3 Mexico RNAi Technology Market Outlook, 2021- 2032
- 7. Europe RNAi Technology Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe RNAi Technology Market Trends and Growth Opportunities
- 7.2.1 Europe RNAi Technology Market Outlook by Type
- 7.2.2 Europe RNAi Technology Market Outlook by Application
- 7.3 Europe RNAi Technology Market Outlook by Country
- 7.3.2 Germany RNAi Technology Market Outlook, 2021- 2032
- 7.3.3 France RNAi Technology Market Outlook, 2021- 2032
- 7.3.4 The UK RNAi Technology Market Outlook, 2021- 2032
- 7.3.5 Spain RNAi Technology Market Outlook, 2021- 2032
- 7.3.6 Italy RNAi Technology Market Outlook, 2021- 2032
- 7.3.7 Russia RNAi Technology Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe RNAi Technology Market Outlook, 2021- 2032
- 8. Asia Pacific RNAi Technology Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific RNAi Technology Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific RNAi Technology Market Outlook by Type
- 8.2.2 Asia Pacific RNAi Technology Market Outlook by Application
- 8.3 Asia Pacific RNAi Technology Market Outlook by Country
- 8.3.1 China RNAi Technology Market Outlook, 2021- 2032
- 8.3.2 India RNAi Technology Market Outlook, 2021- 2032
- 8.3.3 Japan RNAi Technology Market Outlook, 2021- 2032
- 8.3.4 South Korea RNAi Technology Market Outlook, 2021- 2032
- 8.3.5 Australia RNAi Technology Market Outlook, 2021- 2032
- 8.3.6 South East Asia RNAi Technology Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific RNAi Technology Market Outlook, 2021- 2032
- 9. South America RNAi Technology Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America RNAi Technology Market Trends and Growth Opportunities
- 9.2.1 South America RNAi Technology Market Outlook by Type
- 9.2.2 South America RNAi Technology Market Outlook by Application
- 9.3 South America RNAi Technology Market Outlook by Country
- 9.3.1 Brazil RNAi Technology Market Outlook, 2021- 2032
- 9.3.2 Argentina RNAi Technology Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America RNAi Technology Market Outlook, 2021- 2032
- 10. Middle East and Africa RNAi Technology Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa RNAi Technology Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa RNAi Technology Market Outlook by Type
- 10.2.2 Middle East and Africa RNAi Technology Market Outlook by Application
- 10.3 Middle East and Africa RNAi Technology Market Outlook by Country
- 10.3.1 Saudi Arabia RNAi Technology Market Outlook, 2021- 2032
- 10.3.2 The UAE RNAi Technology Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East RNAi Technology Market Outlook, 2021- 2032
- 10.3.4 South Africa RNAi Technology Market Outlook, 2021- 2032
- 10.3.5 Egypt RNAi Technology Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa RNAi Technology Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Alnylam Pharmaceuticals
- Arcturus Therapeutics
- Arrowhead Pharmaceuticals Inc
- Ionis Pharmaceuticals Inc
- Merck & Co. Inc
- Novo Nordisk A/S
- Phio Pharmaceuticals Corp
- Qiagen NV
- Silence Therapeutics PLC
- Thermo Fisher Scientific Inc
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
